IDM CPD-Accredited Seminar: “Reimagine Global Health: The Time is NOW” The RNA Dream: A 4X4 Trail or the High way to Public Health Solutions?

Professor Petro Terblanche holds the position of Chief Executive Officer of Afrigen Biologics (Pty)Ltd based in Cape Town, South Africa.

Afrigen hosts the WHO Global mRNA technology development and transfer Hub and has developed a mRNA technology platform which is being transferred to 15 partners in LMICs as part of a global program to build capacity and capabilities in LMICs to design, develop and produce mRNA vaccines for access and health security.

Prof Terblanche is the author of more than 200 scientific publications and conference papers in public health. Petro holds several Board positions and serves on a number of scientific advisory boards in the academic and public health sector. She was recently acknowledged as one of the legends of science by the Academy of Sciences South Africa.